Government-organised visit to the production line of COVID-19 vaccine by Beijing Institute of Biological...
Unqualified vaccine products are seen on a production line of COVID-19 vaccine inside the Beijing Institute of Biological Products of Sinopharm's China National Biotec Group (CNBG), during a government-organised visit to the company in Beijing, China February 26, 2021. REUTERS/Tingshu Wang